Wellgistics Health Achieves Stability in First-Half 2025 and Executes Growth Initiatives

August 20, 2025 9:00 AM

Wellgistics Health, Inc. (NASDAQ:WGRX) ("Wellgistics Health" or the "Company"), a leader in next-generation pharmaceutical distribution, digital prescription routing, and AI-powered hub fulfillment, today announced financial results for the second fiscal quarter ended June 30, 2025.Financial ResultsRevenue on a pro forma basis, which reflects results as if Wellgistics' distribution operations had been part of the Company for the full comparable...

Read more

ESSE Care Hosts Inaugural Summer Soirée: Uniting NYC's Brightest Healthcare Providers at the Shafer Clinic Sky Terrace

August 20, 2025 8:00 AM

ESSE Care and Wellness, a leading boutique surgical endometriosis and reproductive health practice, hosted its first Summer Soirée - an exclusive gathering of New York City's brightest healthcare providers - at the Shafer Clinic Sky Terrace. The event, flawlessly produced by Revel Rouge, brought together top physicians, surgeons, fertility specialists, nutrition experts, physical therapists, Eastern and Western medicine providers, and other...

Read more

A Full-Service Marketing Agency Called Vertex Viral is Setting a New Standard in Marketing

August 20, 2025 7:20 AM

Vertex Viral, a highly rated and trusted marketing agency in Florida, is setting a new global standard for full-service digital marketing agencies. By delivering SEO-driven, ROI-focused marketing solutions, Vertex Viral helps businesses dominate search results, attract qualified leads, and scale revenue across local, national, and international markets. As one of the best marketing agencies for businesses in Florida and beyond, Vertex Viral...

Read more

DEA Unconstitutional Marijuana Playbook: How the DEA Is Repeating the DOL's Mistakes Against MMJ BioPharma

August 20, 2025 5:00 AM

In a landmark July 2025 decision, the Third Circuit Court of Appeals delivered a stinging rebuke to the Department of Labor for violating the Constitution through its system of in-house courts where agency employees served as prosecutor, judge, and jury. The case involved the Marino family, whose fourth-generation New Jersey farm was driven into collapse over a paperwork error and $500,000 in fines. Yet even as this decision was being celebrated...

Read more

AlzeCure Appoints Cecilia Wadell as New Head of Development

August 20, 2025 4:20 AM

AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical company that develops candidate drugs for diseases affecting the nervous system, focusing on Alzheimer's disease and pain, has appointed Cecilia Wadell, MScPharm, Ph.D., as Head of Development. She will be part of AlzeCure's management team. Her predecessor, Dr. Märta Segerdahl, will continue to focus on her role as CMO of AlzeCure.Cecilia Wadell will take up her position as Head of...

Read more

Alomone Labs Integrates Bioz Pro Badges and a Bioz Content Hub to Elevate Research Visibility and Enhance the User Experience

August 20, 2025 4:00 AM

Bioz, Inc., a trusted source for AI-enhanced research insights and citation transparency, is pleased to announce the impactful integration of Bioz Badges and a Bioz Content Hub for Alomone Labs, a leading manufacturer of research tools for ion channels, receptors, and neuroscience. This strategic collaboration has transformed how Alomone showcases product citations, providing researchers with powerful tools to access scientific data more...

Read more

BioNxt Fast-Tracks U.S. Patent for MS Drug and Secures Broad Platform IP Covering Autoimmune Neurology Pipeline

August 20, 2025 3:05 AM

BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:BXT), a bioscience company specializing in innovative drug delivery technologies, is pleased to announce two key milestones in the expansion and protection of its proprietary drug delivery platform targeting neurological autoimmune disorders. The Company has formally initiated the prioritized examination process for its U.S. patent application for BNT23001, a novel...

Read more

Spago Nanomedical Interim Report January-June, 2025

August 20, 2025 2:20 AM

Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F)APRIL - JUNE IN BRIEFNet sales for the quarter amounted to KSEK 81 (KSEK 459)The loss for the quarter amounted to KSEK -6,964 (KSEK -8,152)Operating expenses for the quarter amounted to KSEK -8,291 (KSEK -10,255)Earnings per share, before and after dilution, for the quarter amounted to SEK -0.02 (SEK -0.03)Cash and cash equivalents at the end of the quarter amounted to KSEK 18,517 (KSEK 47,700)JANUARY -...

Read more

ANGLE Announces Collaboration with Myriad Genetics

August 20, 2025 2:00 AM

ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) solutions for use in research, drug development and clinical oncology, is delighted to announce that it has entered a collaboration with Myriad Genetics, Inc. (MYGN:NSQ), a leading molecular diagnostic testing and precision medicine company dedicated to advancing health and well-being for all.Under the terms of the agreement,...

Read more

Bionic Bloom Chooses NBX Wellness to Offer Genetic Testing and Personalized Peptide Therapies

August 19, 2025 9:15 PM

Bionic Bloom, the nation's first legal psilocybin therapy center and a leader in integrative mental health, has announced a groundbreaking collaboration with NBX Wellness to provide advanced nutrigenomics testing. This collaboration allows patients to receive tailored detoxification, supplementation, and peptide therapy plans based on their unique genetic profiles.The nutrigenomics platform from NBX Wellness empowers practitioners to analyze...

Read more

ADM Tronics Reports First Quarter of Fiscal Year 2026 Results

August 19, 2025 4:50 PM

ADM Tronics Unlimited, Inc. (OTCQB:ADMT), a technology-based developer and manufacturer of innovative technologies and products, announces results for its first fiscal quarter ended June 30, 2025 of Fiscal Year 2025.The upward trend in revenues, as reported in the Company's Annual 10-K Report for the fiscal year ended March 31, 2025, continues for this first fiscal quarter ended June 30, 2025 of the fiscal year ended March 31, 2026, ADMT had an...

Read more

Jaguar Health Reports Approval of All Proposals at August 2025 Annual Meeting of Stockholders

August 19, 2025 4:15 PM

Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today announced the voting results of the Company's Annual Meeting of Stockholders held on August 19, 2025 (the "Annual Meeting").Seven proposals were submitted to and approved by the stockholders of the Company at the Annual Meeting. The proposals are described in detail in the Company's definitive proxy statement on Schedule 14A relating to the Annual Meeting and supplemental...

Read more

CannaPharmaRX Expands Cannabis Exports, Projects $1M+ Q3 Revenue

August 19, 2025 2:30 PM

CannaPharmaRX, Inc. (OTC PINK:CPMD), an emerging leader in global cannabis cultivation and exports, announces a series of strategic developments. The goal is to strengthen its international footprint and production capacity.The company continues to make significant steps in its mission to supply premium cannabis products to high-demand international markets, including Germany, Portugal, and Israel. Here's an overview of their recent shipments...

Read more

Transparent Co-Management: The Future of Hospital and SNF Rehab

August 19, 2025 12:00 PM

The world of healthcare has changed drastically since the COVID-19 pandemic, and as both hospitals and SNFs are increasingly tasked with doing more with less, a contract rehabilitative service like BenCura can be the solution to many of the problems both hospitals and skilled nursing facilities are facing. At BenCura, we can help your facility provide quality rehabilitative care to patients or residents less expensively than traditional in-house...

Read more

ASCP Strengthens Voice in Senior Care: Chad Worz Joins PQM PAC/LTC Committee, Along With BOD Members Rob Accetta and Rob Leffler

August 19, 2025 12:00 PM

The American Society of Consultant Pharmacists (ASCP) proudly announces the appointment of Chief Executive Chad Worz, PharmD, BCGP, FASCP, to the Partnership for Quality Measurement's (PQM) Pre-Rulemaking Measure Review (PRMR) Post-Acute Care/Long-Term Care (PAC/LTC) Committee.PQM committees bring together a diverse array of voices-from providers to patient advocates - to ensure that quality measures reflect real care priorities. The PAC/LTC...

Read more

ForCast Orthopedics Announces Expansion of Scientific Advisory Board

August 19, 2025 10:00 AM

ForCast Orthopedics today announced the expansion of its Scientific Advisory Board (SAB) with the addition of Matthew P. Abdel, MD, and R. Michael Meneghini, MD. Both Dr. Abdel and Dr. Meneghini are recognized leaders in the diagnosis and treatment of periprosthetic joint infection (PJI), and both bring decades of clinical and research experience to further strengthen ForCast's SAB."Adding both Dr. Abdel and Dr. Meneghini to our SAB...

Read more

Belhaven Biopharma Closes Oversubscribed Series a to Fund the Development of Nasdepi(R) Program Moves Into Late Stage Clinical and Manufacturing Through NDA Approval

August 19, 2025 10:00 AM

Belhaven Biopharma, a clinical-stage biopharmaceutical company advancing innovative dry powder nasal drug delivery solutions, today announced the close of an oversubscribed Series A financing round, completed in just six weeks. With an initial target of $10 million, the round drew strong interest from both new and existing investors, marking the company's fifth successful capital raise since its founding.Proceeds from the Series A will enable...

Read more

MDCE Readies Major Share Reduction After 2,500% Q2 Revenue Surge

August 19, 2025 9:11 AM

Medical Care Technologies Inc. (OTC Pink:MDCE) today provided a corporate update highlighting important operational progress and structural initiatives designed to enhance long-term shareholder value.Following its recently reported 2,500% year-over-year revenue growth in Q2 2025, the Company is pleased to announce that it has successfully initiated onboarding with a new transfer agency. This step clears the path for MDCE to move forward with its...

Read more

Trulla Helps Baptist Health With Procurement Processes for Autonomous Pharmacy

August 19, 2025 9:00 AM

SpendMend, a leading provider of solutions to optimize the cost-cycle for the healthcare industry, announced today that Baptist Health is now live with Trulla by SpendMend to streamline and enhance its procurement processes for the health system's autonomous pharmacy.Trulla is a cloud-based application developed by pharmacists to enable health systems to manage pharmacy ordering across multiple locations within a single system. This innovative...

Read more

Jaguar Health Family Company Napo Pharmaceuticals to Meet with FDA to Discuss Potential Regulatory Pathways for Crofelemer for Treatment of Ultrarare Pediatric Indication Microvillus Inclusion Disease (MVID)

August 19, 2025 9:00 AM

Jaguar Health, Inc. (NASDAQ:JAGX) (Jaguar) family company Napo Pharmaceuticals (Napo) today announced that it plans to meet with the U.S. Food and Drug Administration (FDA) to discuss the company's ongoing clinical development program for crofelemerfor the treatment of microvillus inclusion disease (MVID), an ultrarare pediatric disorder. Members of Napo's Scientific Advisory Board will join Napo and Jaguar representatives at the meeting."We're...

Read more